Recall: Quinapril
Jan. 2023Pharmacy Updates
Lupin Pharmaceuticals Inc. has recalled four lots of Quinapril Tablets because they contain of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level. Such impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time. Read the full text of the Quinapril recall.
Recent Announcements
CME Webinar: Oral Health In Your Pediatric Office
Please join us for a live, CME-accredited webinar on Wednesday, Oct. 14 that will provide an overview of oral health in your pediatric office.Sep. 2026Education/Webinars
Medicaid Renewal
Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.Aug. 2026Important Notices
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Aug. 2026Important Notices